AzTrials
AzTrials

Breast CancerEXERCISE DIEPNCT07672392

The Effect of a Post-operative Exercise Programme Versus Standard Care on Physical Fitness of Patients With Breast Cancer Undergoing Deep Inferior Epigastric Perforator (DIEP) Flap Reconstruction Surgery

A study testing Structured individualised 12-week post operative exercise programme in people with Breast Cancer and Exercise, run by Royal College of Surgeons, Ireland at 1 site in Ireland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

All patients undergoing mastectomy for breast cancer should be offered the option of reconstructive surgery. The Deep Inferior Epigastric Perforator Flap or DIEP reconstruction as it is commonly referred to, is becoming the favoured reconstruction by both patients and surgeons as it gives a great cosmetic outcome as… Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Breast Cancer, Exercise
What is being tested?
Structured individualised 12-week post operative exercise programme
Could I receive a placebo?
No, everyone receives an active treatment
How many people
78 participants
Where
1 siteIreland
Study dates
1 Aug 2024to 30 Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Women aged 18 years and older
  • Candidates who have already been selected to undergo mastectomy and reconstruction by the breast MDT for the following indications:
  • Genetic mutation carriers undergoing risk-reducing mastectomy.
  • Ductal carcinoma in situ (DCIS) requiring mastectomy.
  • Early invasive breast cancer requiring mastectomy.
  • The tumour must not have skin involvement and no evidence of invasive disease within 1cm of skin, nipple or pectoralis major muscle (as proven on MRI).
Show all 9Show fewer
  • Candidates for breast reconstruction with DIEP.
  • Fluent in English
  • Fit for general anaesthetic Signed informed consent form

Who cannot join

  • Advanced breast cancer with skin involvement.
  • Undergoing bilateral DIEP reconstruction or other forms of breast reconstruction (e.g., TRAM, implant-based, LD flap).
  • Pregnancy
  • Lactation Patients with insufficient English to sign an informed consent (i.e. interpreter required).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Arnold Hill, MB, BCh, BAO, MCh, FRCSI contact

+35318093000

adkhill@rcsi.com

Aisling Hegarty, PhD contact

018093000

Aislinghegarty@rcsi.ie

Ireland1 site, 1 recruiting
  • Beaumont RCSI Cancer Centre

    Beaumont, Dublin, D09V2N0

    Recruiting

Other trials in Ireland

About this study

All patients undergoing mastectomy for breast cancer should be offered the option of reconstructive surgery. The Deep Inferior Epigastric Perforator Flap or DIEP reconstruction as it is commonly referred to, is becoming the favoured reconstruction by both patients and surgeons as it gives a great cosmetic outcome as well as being a good option for patients who may have to undergo radiotherapy treatment after their surgery.

Exercise has been demonstrated in previous research to improve tolerance of treatment (particularly chemotherapy), post operative fatigue and the overall quality of life in patients undergoing cancer treatment. Furthermore, it has shown to improve survival in patients who are being treated for breast cancer. The investigators are undertaking this study to investigate whether a structured exercise programme will improve patients fitness after surgery and ultimately improve their recovery after their reconstructive surgery. To do this, half of the people taking part will be undertaking a structured exercise programme and the other half will not and will be assessing which group recover better after their surgery. Currently, no breast reconstruction patients in Ireland are receiving a formal "exercise prescription" after their surgery so will be looking to see if this helps people recover better before it is made standard care for every breast patient in Ireland.

Read the detailed description

Primary Objective:

To evaluate the impact of a structured, post-operative exercise programme on patient-reported and functional outcomes following DIEP flap breast reconstruction.

Secondary Objectives:

  • To examine the effects of the exercise programme on upper and lower limb strength, body composition (BMI, fat and muscle mass, bone density), and functional recovery.
  • To evaluate the influence of exercise on post-operative complication rates, length of hospital stay and time to return to daily activities.
  • To explore changes in psychological health and body image perception using validated questionnaires.
  • To assess adherence, feasibility, and safety of the structured exercise programme within a breast reconstruction population.
  • To perform an exploratory health-economic analysis comparing the costs and potential healthcare savings associated with the intervention versus standard care.
Being tested
Structured individualised 12-week post operative exercise programme
Keywords
Breast cancer, DIEP Reconstruction, Exercise
Medical subject headings
Breast Neoplasms, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Structured individualised 12-week post operative exercise programmeBehavioural

    Structured individualised 12-week post operative exercise programme based on ACSM oncology guidelines, incorporating aerobic, resistance and flexibility training delivered in person or via zoom.

Study groups in NCT07672392
Study groupRoleWhat they receive
InterventionExperimentalStructured individualised 12-week post operative exercise programme based on ACSM oncology guidelines, incorporating aerobic, resistance and flexibility training delivered in person or via zoom.
Receives: Behavioral: Structured individualised 12-week post operative exercise programme
ControlNo interventionstandard post-operative care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cardiorespiratory Fitness

    Cardiorespiratory fitness measured using the 6-Minute Walk Test (6MWT). Outcome reported as change in distance walked (metres) from baseline to 6 months post-operatively. Greater distance indicates improved cardiorespiratory fitness.

    Measured: Measured at baseline (recruitment), 6 months postoperatively and at 1 year postoperatively

Secondary outcomes (7)
  1. Hand Grip Strength

    Measured using a hand dynamometer and reported in kilograms.

    Measured: 6 months and 12 months post operatively

  2. Body Mass Index

    Body mass index (BMI) calculated from measured weight and height and reported in kilograms per square meter (kg/m²).

    Measured: At six months and 12 months postoperatively

  3. EQ5D5L Health Related Quality of Life

    Quality of Life and Psychosocial Health: Assessed using the BREAST-Q (psychosocial and sexual well-being domains)

    Measured: At 6 months and 12 months post operatively

  4. Percentage Body Fat

    Percentage body fat measured using bioelectrical impedance analysis with a Tanita device and reported as percentage body fat (%).

    Measured: At 6 months and 12 months postoperatively

  5. Muscle Mass

    Muscle mass measured using bioelectrical impedance analysis with a Tanita device and reported in kilograms (kg).

    Measured: At 6 months and 12 months postoperatively

  6. Bone Mass

    Bone mass measured using bioelectrical impedance analysis with a Tanita device and reported in kilograms (kg).

    Measured: At 6 months and 12 months postoperatively

  7. Lower Limb Strength

    Measured using the 30 second Sit to Stand Test

    Measured: Measured at 6 months and 1 year postoperatively.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jun 2026
  2. Study start1 Aug 2024
  3. Primary completion30 Dec 2027 (estimated)
  4. Study completion30 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a randomised control trial that seeks to evaluate the impact of a structured, post-operative exercise programme on patient-reported and functional outcomes following DIEP flap breast reconstruction.
Masking
None (open label)
Enrolment
78 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07672392
Sponsor's protocol ID
23-41
Acronym
EXERCISE DIEP
Status last verified
Feb 2026
First submitted
16 Feb 2026
Last updated
26 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared as this could potentially identify participants. Anonymous datasets will be available for validation.

Questions about this trial

What is this clinical trial studying?

A study testing Structured individualised 12-week post operative exercise programme in people with Breast Cancer and Exercise, run by Royal College of Surgeons, Ireland at 1 site in Ireland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 26 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Ireland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Arnold Hill, MB, BCh, BAO, MCh, FRCSI (+35318093000, adkhill@rcsi.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cardiorespiratory Fitness (time frame: Measured at baseline (recruitment), 6 months postoperatively and at 1 year postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
EXERCISE DIEP Clinical Trial NCT07672392 | AzTrials